Lithium 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate
orotic acid lithium salt monohydrate
CAS: 5266-20-6
Molecular Formula: C5H5LiN2O4
Lithium 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate - Names and Identifiers
Lithium 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate - Physico-chemical Properties
| Molecular Formula | C5H5LiN2O4 |
| Molar Mass | 164.05 |
| Melting Point | ≥300°C |
| Physical and Chemical Properties | Lithium orotate, also known as vitamin B13. White shiny needle-like crystals or crystalline powder obtained from water, odorless and sour. The melting point was 345-346 °c. Insoluble in cold water and ethanol, slightly soluble in hot water. The reaction with hydrogen peroxide and concentrated hydrochloric acid produces 5-chlorouracil -4-carboxylic acid. Diethyl butyrate can be synthesized from diethyl oxalate and ethyl acetate, and obtained by hydrolysis after cyclization with urea. Medicine for the treatment of jaundice and general liver dysfunction disease. |
Lithium 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate - Risk and Safety
| Safety Description | S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. |
Lithium 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate - Reference Information
| EPA chemical information | Information provided by: ofmpub.epa.gov (external link) |
Last Update：2024-04-09 02:00:05
